BBCMF (Lir Life Sciences) Current Accrued Expense: $0.06 Mil (As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BBCMF Lir Life Sciences Corp BBCMF
15 GF Score
Price $0.05
View Full Analysis

What is Lir Life Sciences Current Accrued Expense?

Lir Life Sciences BBCMF 15 Current Accrued Expense is $0.06 Mil as of Jan. 2026. GuruFocus rates BBCMF with a GF Score™ of 15/100.

Lir Life Sciences's Current Accrued Expense for the quarter that ended in Jan. 2026 was $0.06 Mil.

Lir Life Sciences's quarterly Current Accrued Expense increased from Jul. 2025 ($0.00 Mil) to Oct. 2025 ($0.01 Mil) and increased from Oct. 2025 ($0.01 Mil) to Jan. 2026 ($0.06 Mil).

Lir Life Sciences Current Accrued Expense Related Terms

Lir Life Sciences Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Lir Life Sciences's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lir Life Sciences Current Accrued Expense Chart

Lir Life Sciences Annual Data
Trend Apr24 Apr25
Current Accrued Expense
0.00 0.00

Lir Life Sciences Quarterly Data
Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Current Accrued Expense Get a 7-Day Free Trial 0.00 0.00 0.00 0.01 0.06
BBCMF
15GF Score
Lir Life Sciences Corp BBCMF
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lir Life Sciences Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $0.06 Mil mean?
Lir Life Sciences (BBCMF) has a Current Accrued Expense of $0.06 Mil as of Jan. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Lir Life Sciences and its competitors.
Is Lir Life Sciences' Current Accrued Expense too high?
Lir Life Sciences' current Current Accrued Expense is $0.06 Mil. Overall, Lir Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Lir Life Sciences' Current Accrued Expense compare to VRTX and REGN?
Lir Life Sciences' Current Accrued Expense of $0.06 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Biotechnology company?
A good Current Accrued Expense depends on the Biotechnology industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Lir Life Sciences and its competitors. Lir Life Sciences's current Current Accrued Expense is $0.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lir Life Sciences stock overvalued right now?
Lir Life Sciences (BBCMF) has a current Current Accrued Expense of $0.06 Mil. The current Current Accrued Expense is $0.06 Mil. Lir Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Lir Life Sciences (BBCMF), the current Current Accrued Expense is $0.06 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lir Life Sciences Business Description

Other Exchanges N790:GermanySKNY:Canada
Address 505-1505 West 2nd Avenue, Vancouver, BC, CAN, V6J 1H2
Lir Life Sciences Corp is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the focus of improving accessibility and patient experience.
15GF Score

Get the complete analysis for BBCMF

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.05
Price